Sugi Predict

Sugi Predict / Compounds / SCHEMBL15420570

SCHEMBL15420570

SCHEMBL15420570

CCS(=O)(=O)N[C@H]1CCCO[C@@H]1COc1ccc(-c2ncc(Cl)cc2F)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RX3 P56373 3/20 0.38
▸ P2RX2 Q9UBL9 3/20 0.38
▸ RAB9A P51151 6/20 0.35
▸ LMNA P02545 3/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ RXFP1 Q9HBX9 1/20 0.35
▸ SMO Q99835 2/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ NPC1 O15118 4/20 0.33
▸ GRM5 P41594 1/20 0.33
▸ ALDH1A1 P00352 4/20 0.33
▸ SMN1; SMN2 Q16637 3/20 0.33
▸ KDM4E B2RXH2 3/20 0.33
▸ HPGD P15428 2/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ GAA P10253 2/20 0.32
▸ MAPT P10636 2/20 0.32
▸ POLB P06746 1/20 0.32
▸ KAT8 Q9H7Z6 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15420617 0.92 SMO (0.40) P2RX3P2RX2RAB9ALMNANPSR1
SCHEMBL15420523 0.86 NPC1 (0.44) RAB9ALMNANPC1ALDH1A1SMN1; SMN2
SCHEMBL15420431 0.85 P2RX3 (0.41) P2RX3P2RX2RAB9ALMNANPSR1
SCHEMBL15420213 0.84 LMNA (0.38) RAB9ALMNAL3MBTL1NPC1ALDH1A1
SCHEMBL12987872 0.82 P2RX3 (0.37) P2RX3P2RX2SMOGRM5MAPK1
SCHEMBL15420477 0.82 P2RX3 (0.37) P2RX3P2RX2SMOGRM5MAPK1
SCHEMBL15420688 0.82 P2RX3 (0.37) P2RX3P2RX2SMOGRM5MAPK1
SCHEMBL15420566 0.82 P2RX3 (0.37) P2RX3P2RX2SMOGRM5MAPK1
SCHEMBL15420711 0.82 RAB9A (0.37) RAB9ALMNANPSR1RXFP1NPC1
SCHEMBL15420323 0.81 P2RX3 (0.39) P2RX3P2RX2RAB9ALMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2694472-B1 SULFONAMIDE DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICALS CO (JP) 2020-03-11 — — EP disclosed
US-9527807-B2 Sulfonamide derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-12-27 — — US disclosed
US-9527807-B2 Sulfonamide derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-12-27 — — US disclosed
US-9527807-B2 Sulfonamide derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-12-27 — — US disclosed
US-20140024650-A1 SULFONAMIDE DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2014-01-23 — — US disclosed
US-20140024650-A1 SULFONAMIDE DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2014-01-23 — — US disclosed
US-20140024650-A1 SULFONAMIDE DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2014-01-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140024650-A1 SULFONAMIDE DERIVATIVE AND USE THEREOF GRIN2A, GRIN2B, SLC1A2 P2RX3 1163/4885P2RX2 730/4885RAB9A 3305/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.